Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance

Journal of Clinical Microbiology

Volumn 48, Issue 9, 2010, Pages 3158-3164

  Yang, Chunfu ^a   McNulty, Amanda ^a   Diallo, Karidia ^a   Zhang, Jing ^a,b   Titanji, Boghuma ^c   Kassim, Sidibe ^a   Wadonda Kabondo, Nellie ^d   Aberle Grasse, John ^a   Kibuka, Tabitha ^e   Ndumbe, Peter M ^c   Vedapuri, Shanmugam ^a   Zhou, Zhiyong ^a   Chilima, Benson ^d   Nkengasong, John N ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b SHANDONG CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d MINISTRY OF HEALTH   (Malawi)

^e CDC GAP   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; PROTEINASE; ZIDOVUDINE;

ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; GENETIC SCREENING; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCREENING TEST; VIROTHERAPY; VIRUS LOAD; VIRUS STRAIN;

BLOOD; CAMEROON; CHINA; DESICCATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALAWI; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SPECIMEN HANDLING; TANZANIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77956841160     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00564-10     Document Type: Article

References (37)

1. Alaeus, A., K. Lidman, A. Sonnerborg, and J. Albert. 1997. Subtypespecific problems with quantification of plasma HIV-1 RNA. AIDS 11: 859-865. (Pubitemid 27226408)
2. Beddows, S., S. Galpin, S. H. Kazmi, A. Ashraf, A. Johargy, A. J. Frater, N. White, R. Braganza, J. Clarke, M. McClure, and J. N. Weber. 2003. Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes. J. Med. Virol. 70:337-342.
3. Bennett, D. E., R. J. Camacho, D. Otelea, D. R. Kuritzkes, H. Fleury, M. Kiuchi, W. Heneine, R. Kantor, M. R. Jordan, J. M. Schapiro, A. M. Vandamme, P. Sandstrom, C. A. Boucher, D. van de Vijver, S. Y. Rhee, T. F. Liu, D. Pillay, and R. W. Shafer. 2009. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS. ONE 4:e4724.
4. Bennett, D. E., M. Myatt, S. Bertagnolio, D. Sutherland, and C. F. Gilks. 2008. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir. Ther. 13(Suppl. 2):25-36.
5. Bertagnolio, S., L. Soto-Ramirez, R. Pilon, R. Rodriguez, M. Viveros, L. Fuentes, P. R. Harrigan, T. Mo, D. Sutherland, and P. Sandstrom. 2007. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther. 12:107-113.
6. Brambilla, D., C. Jennings, G. Aldrovandi, J. Bremer, A. M. Comeau, S. A. Cassol, R. Dickover, J. B. Jackson, J. Pitt, J. L. Sullivan, A. Butcher, L. Grosso, P. Reichelderfer, and S. A. Fiscus. 2003. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J. Clin. Microbiol. 41:1888-1893.
7. Buckton, A. J., S. L. Bissett, R. E. Myers, S. Beddows, S. Edwards, P. A. Cane, and D. Pillay. 2008. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. J. Antimicrob. Chemother. 62:1191-1198.
8. Cassol, S. A., S. Read, B. G. Weniger, P. Gomez, N. Lapointe, C. Y. Ou, and P. G. Babu. 1996. Dried blood spots collected on filter paper: an international resource for the diagnosis and genetic characterization of human immunodeficiency virus type-1. Mem. Inst. Oswaldo Cruz 91:351-358.
9. Eberle, J., I. Loussert-Ajaka, S. Brust, L. Zekeng, P. H. Hauser, L. Kaptue, S. Knapp, F. Damond, S. Saragosti, F. Simon, and L. G. Gurtler. 1997. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection. J. Virol. Methods 67:85-91.
10. Eshleman, S. H., G. Becker-Pergola, M. Deseyve, L. A. Guay, M. Mracna, T. Fleming, S. Cunningham, P. Musoke, F. Mmiro, and J. B. Jackson. 2001. Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV network for prevention trials 012 study). J. Infect. Dis. 184: 914-917.
11. Fontaine, E., C. Riva, M. Peeters, J. C. Schmit, E. Delaporte, K. Van Laethem, K. Van Vaerenbergh, J. Snoeck, E. Van Wijngaerden, E. De Clercq, M. Van Ranst, and A. M. Vandamme. 2001. Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J. J. Acquir. Immune Defic. Syndr. 28:254-258.
12. Garcia-Lerma, J. G., A. McNulty, C. Jennings, D. Huang, W. Heneine, and J. W. Bremer. 2009. Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity. J. Antimicrob. Chemother. 64: 33-36.
13. Garrick, M. D., P. Dembure, and R. Guthrie. 1973. Sickle-cell anemia and other hemoglobinopathies. Procedures and strategy for screening employing spots of blood on filter paper as specimens. N. Engl. J. Med. 288:1265-1268.
14. Garrick, M. D., A. P. Orfanos, L. Rogers, E. W. Naylor, and R. Guthrie. 1981. A simple screening test for reduced glutathione in filter paper spots of blood. J. Pediatr. 98:265-267.
15. Hall, T. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 96/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
16. Hallack, R., L. E. Doherty, J. A. Wethers, and M. M. Parker. 2008. Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay. J. Clin. Virol. 41:283-287.
17. Hamers, R. L., P. W. Smit, W. Stevens, R. Schuurman, and T. F. Rinke de Wit. 2009. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir. Ther. 14:619-629.
18. Johannessen, A., C. Garrido, N. Zahonero, L. Sandvik, E. Naman, S. L. Kivuyo, M. J. Kasubi, S. G. Gundersen, J. N. Bruun, and C. de Mendoza. 2009. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin. Infect. Dis. 49:976-981.
19. Kamoto, K., J. Aberle-Grasse, and Malawi HIV Drug Resistance Task Force. 2008. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi. Antivir. Ther. 13(Suppl. 2):83-87. (Pubitemid 352019093)
20. Kane, C. T., H. D. Ndiaye, S. Diallo, I. Ndiaye, A. S. Wade, P. A. Diaw, A. Gaye-Diallo, and S. Mboup. 2008. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal. J. Virol. Methods 148:291-295.
21. Loussert-Ajaka, I., M. L. Chaix, B. Korber, F. Letourneur, E. Gomas, E. Allen, T. D. Ly, F. Brun-Vezinet, F. Simon, and S. Saragosti. 1995. Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J. Virol. 69:5640-5649.
22. Luo, W., H. Yang, K. Rathbun, C. P. Pau, and C. Y. Ou. 2005. Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay. J. Clin. Microbiol. 43:1851-1857.
23. Masciotra, S., C. Garrido, A. S. Youngpairoj, A. McNulty, N. Zahonero, A. Corral, W. Heneine, C. de Mendoza, and J. G. Garcia-Lerma. 2007. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. AIDS 21:2503-2511.
24. McNulty, A., K. Diallo, J. Zhang, B. Titanji, S. Kassim, D. Bennett, J. Abert-Grasse, T. Kibuka, P. M. Ndumbe, J. N. Nkengasong, and C. Yang. 2008. Development and application of a broadly sensitive genotyping assay for surveillance of HIV-1 drug resistance in PEPFAR countries. Antivir. Ther. 13:A117.
25. McNulty, A., C. Jennings, D. Bennett, J. Fitzgibbon, J. W. Bremer, M. Ussery, M. L. Kalish, W. Heneine, and J. G. Garcia-Lerma. 2007. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J. Clin. Microbiol. 45:517-521.
26. Monleau, M., C. Montavon, C. Laurent, M. Segondy, B. Montes, E. Delaporte, F. Boillot, and M. Peeters. 2009. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. J. Clin. Microbiol. 47:1107-1118.
27. Ou, C. Y., H. Yang, S. Balinandi, S. Sawadogo, V. Shanmugam, P. M. Tih, C. dje-Toure, S. Tancho, L. K. Ya, M. Bulterys, R. Downing, and J. N. Nkengasong. 2007. Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon. J. Virol. Methods 144:109-114.
28. Plantier, J. C., R. Dachraoui, V. Lemee, M. Gueudin, F. Borsa-Lebas, F. Caron, and F. Simon. 2005. HIV-1 resistance genotyping on dried serum spots. AIDS 19:391-397.
29. Ribas, S. G., L. Heyndrickx, P. Ondoa, and K. Fransen. 2006. Performance evaluation of the two protease sequencing primers of the Trugene HIV-1 genotyping kit. J. Virol. Methods 135:137-142.
30. Somi, G. R., T. Kibuka, K. Diallo, T. Tuhuma, D. E. Bennett, C. Yang, C. Kagoma, E. F. Lyamuya, R. O. Swai, and S. Kassim. 2008. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. Antivir. Ther. 13(Suppl. 2):77-82.
31. Stevens, W., G. Sherman, R. Downing, L. M. Parsons, C. Y. Ou, S. Crowley, G. M. Gershy-Damet, K. Fransen, M. Bulterys, L. Lu, J. Homsy, T. Finkbeiner, and J. N. Nkengasong. 2008. Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis. Open AIDS J. 2:17-25.
32. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
33. Tong, C. Y., J. Mullen, R. Kulasegaram, A. De Ruiter, S. O'Shea, and I. L. Chrystie. 2005. Genotyping of B and non-B subtypes of human immunodeficiency virus type 1. J. Clin. Microbiol. 43:4623-4627.
34. World Health Organization. 2004. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach, 2003 revision. World Health Organization, Geneva, Switzerland.
35. Youngpairoj, A. S., S. Masciotra, C. Garrido, N. Zahonero, C. de Mendoza, and J. G. Garcia-Lerma. 2008. HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C. J. Antimicrob. Chemother. 61:1217-1220.
36. Zhang, J., D. Kang, J. Fu, X. Sun, B. Lin, Z. Bi, J. N. Nkengasong, and C. Yang. 2010. Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed HIV type 1-infected patients in Shandong Province, China. AIDS Res. Hum. Retroviruses 26:99-103.
37. Ziemniak, C., A. George-Agwu, W. J. Moss, S. C. Ray, and D. Persaud. 2006. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J. Virol. Methods 136:238-247. (Pubitemid 44051599)